Key result
EV71 RT-dPCR achieves 100% diagnostic agreement with standard qPCR in pediatric patients.
Why the study?
RT-qPCR often yields false-negative results during early EV71 infection due to low viral load, prompting development of a more sensitive diagnostic assay.
Does a microfluidic digital PCR assay improve the detection of Enterovirus 71 in pediatric patients with hand, foot, and mouth disease compared to standard qPCR?
Cross-Sectional (n=60)
No
Does a microfluidic digital PCR assay improve the detection of Enterovirus 71 in pediatric patients with hand, foot, and mouth disease compared to standard qPCR?
Effect estimate: kappa 1.0
p-value: p=<0.001
The developed EV71 RT-dPCR assay provides a highly sensitive and specific method for the early differential diagnosis of EV71-induced hand, foot, and mouth disease, overcoming the false-negative limitations of standard RT-qPCR.
May aid EV71 detection in pediatric HFMD if replicated; leaves open superiority to qPCR and routine adoption.
Enterovirus71 (EV71) is a major etiological agent of severe hand, foot, and mouth disease (HFMD), which can lead to central nervous system damage in children. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) often produces false-negative results during the early stage of EV71 infection, attributable to the low viral load. To address this limitation, we developed a rapid, precise, and highly sensitive multiplex reverse transcription digital polymerase chain reaction (RT-dPCR) assay for differential diagnosis of EV71-induced HFMD and non-EV71 pathogens. The EV71 RT-dPCR assay targeted the viral structural protein VP2 using a TaqMan minor groove binder (MGB) probe. This method achieved a detection sensitivity of 7.406 copies per microliter. Specificity analysis confirmed no cross-reactivity with non-EV71 enteroviruses. When validated against 60 clinical samples, the assay demonstrated 100% overall agreement (60/60) with a kappa value of 1.0 (p < 0.001). The developed EV71 RT-dPCR assay may facilitate early diagnosis of severe EV71-associated HFMD, enabling timely intervention for affected children.
No takes yet. Share an insight, caveat, or question.
Rui et al. (2025) conducted a cross-sectional in Hand, foot, and mouth disease (HFMD) (n=60). EV71 RT-dPCR assay vs. Clinical diagnosis (qPCR) was evaluated on Overall agreement with clinical diagnosis (kappa 1.0, p=<0.001). The EV71 RT-dPCR assay demonstrated 100% overall agreement with clinical qPCR diagnosis (kappa = 1.0, p < 0.001) for detecting EV71 in pediatric patients with hand, foot, and mouth disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: